Biotechnology company Creative Medical Technology Holdings, Inc. (CELZ) announced Tuesday that it has received Institutional Review Board (IRB) approval to proceed with its clinical trial for the treatment of chronic lower back pain with its StemSpine procedure using AlloStem (CELZ-201-DDT) cell therapy.
Is Degenerative Disc Disease Work-Related? eyeonannapolis.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eyeonannapolis.net Daily Mail and Mail on Sunday newspapers.